Humira and uveitis
Researchers from the RHAPSODY study, which is examining the efficacy of adalimumab (Humira) on ankylosing spondylitis, report that the incidence of uveitis is markedly reduced among patients receiving the anti-TNF treatment.
Ankylose This! Living with Ankylosing Spondylitis
About Ankylose This!
Ankylose This! is a group blog about life with ankylosing spondylitis. Its authors post about their own experiences, medical news, and useful resources.
Disclaimer: None of us are doctors, and nothing in this blog should be construed as medical advice. We are simply patients trying to make sense of our disease.
- Contributors (+/-)
- Monthly archives (+/-)
- September 2004
- October 2004
- November 2004
- December 2004
- January 2005
- February 2005
- March 2005
- April 2005
- May 2005
- June 2005
- July 2005
- August 2005
- September 2005
- October 2005
- November 2005
- December 2005
- January 2006
- February 2006
- March 2006
- April 2006
- May 2006
- June 2006
- July 2006
- August 2006
- September 2006
- October 2006
- November 2006
- December 2006
- January 2007
- February 2007
- March 2007
- April 2007
- May 2007
- June 2007
- July 2007
- August 2007
- October 2007
- November 2007
- December 2007
- January 2008
- February 2008
- March 2008
- February 2009
- April 2009
- June 2009
- August 2009
- September 2009
- October 2009
- November 2009
- RSS feed
- Current posts
Earlier posts
- NICE to AS patients: No Remicade for you!
- Golimumab and ankylosing spondylitis
- Researchers implicate two genes in development of ...
- TNF antagonists and skin cancer
- Review: Arthritis Without Pain
- Hydrotherapy pool closure affects AS patients
- Newcastle AS study
- People with AS in the news
- It's in the family
- Wellcome Trust images
Comments on this post
Post a Comment
Links to this post
Create a Link